Keep an eye on Carefully (2)pentobarbital will decrease the extent or effect of suvorexant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Sturdy CYP3A4 inducers may perhaps lessen suvorexant efficacy; if enhanced suvorexant dose needed, do not exceed 20 mg/working d